[1]
“EFFECT OF PERIPHERAL NEUROMODULATION ON HEADACHE IN POST COVID-19 SURVIVORS”, Journal of Pharmaceutical Negative Results, pp. 2694–2704, Dec. 2022, doi: 10.47750/pnr.2022.13.S07.361.